Premium
Indian drugmakers Mankind Pharma, Dr Reddy’s Laboratories, and Torrent Pharma are in the race to acquire JB Chemicals & Pharmaceuticals from private equity firm KKR, a media report said. Citing people familiar with the matter, The Economic Times reported that high valuation has deterred some PE firms from bidding for JB ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.